Astellas Pharma’s Post

In research, it is not always possible to design head-to-head trials, comparing different treatments directly. However, we can evaluate treatment outcome profiles of different therapies using matching-adjusted indirect comparison (MAIC) analyses. Professor Andrew Armstrong offers his views on their benefits – as well as limitations - and how their findings can contribute to our understanding of treatment outcomes.  #MAICanalysis #ScienceFirstForPatients

To view or add a comment, sign in

Explore topics